Belmont, MA, United States of America

Christopher Thomson

USPTO Granted Patents = 7 

Average Co-Inventor Count = 7.9

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Billingshurst, GB (2013 - 2014)
  • Horsham, GB (2016)
  • Belmont, MA (US) (2017 - 2019)

Company Filing History:


Years Active: 2013-2019

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations of Christopher Thomson

Introduction

Christopher Thomson is a notable inventor based in Belmont, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his work on autotaxin inhibitors. With a total of seven patents to his name, Thomson's innovations have the potential to impact various diseases and disorders.

Latest Patents

Thomson's latest patents focus on novel compounds that act as autotaxin inhibitors. These inventions include processes for their preparation, pharmaceutical compositions, and medicaments containing these compounds. The applications of these inventions are aimed at treating diseases and disorders mediated by autotaxin, showcasing Thomson's commitment to advancing medical science.

Career Highlights

Throughout his career, Christopher Thomson has worked with prominent companies such as Novartis AG and Irm LLC. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Thomson has collaborated with talented individuals in his field, including Vikki Furminger and Jeffrey McKenna. These partnerships have likely enhanced his research and development efforts, leading to successful innovations.

Conclusion

Christopher Thomson's work as an inventor has led to significant advancements in the field of pharmaceuticals, particularly with his focus on autotaxin inhibitors. His contributions are poised to make a lasting impact on the treatment of various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…